1.
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
by Bulkmans, NWJ, MD
The Lancet (British edition), 2007, Vol.370 (9601), p.1764-1772
2.
Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology
by Kulmala, S-M A
Journal of clinical pathology, 2006-05, Vol.59 (5), p.513-517
3.
Global Burden of Human Papillomavirus and Related Diseases
by Forman, David
Vaccine, 2012, Vol.30, p.F12-F23
4.
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
by Drolet, Mélanie, PhD
The Lancet infectious diseases, 2015, Vol.15 (5), p.565-580
5.
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
by Arbyn, Marc, Dr
The lancet oncology, 2014, Vol.15 (2), p.172-183
6.
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PA...
by Lehtinen, Matti, Prof
The lancet oncology, 2012, Vol.13 (1), p.89-99
7.
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
by de Sanjose, Silvia, Dr
The lancet oncology, 2010, Vol.11 (11), p.1048-1056
8.
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of t...
by Wheeler, Cosette M, Dr, Prof
The lancet oncology, 2012, Vol.13 (1), p.100-110
9.
Human papillomavirus and cervical cancer
by Crosbie, Emma J, PhD
The Lancet (British edition), 2013, Vol.382 (9895), p.889-899
10.
A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
by Schiller, John T
Vaccine, 2012, Vol.30 (5), p.F123-F138
11.
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
by Brotherton, Julia ML, Dr
The Lancet (British edition), 2011, Vol.377 (9783), p.2085-2092
12.
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the AT...
by Castle, Philip E, Dr
The lancet oncology, 2011, Vol.12 (9), p.880-890
13.
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-b...
by Paavonen, J, Prof
The Lancet (British edition), 2009, Vol.374 (9686), p.301-314
14.
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
by Huh, Warner K
The Lancet (British edition), 2017-11-11, Vol.390 (10108), p.2143-2159
15.
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
by Rijkaart, Dorien C, MD
The lancet oncology, 2012, Vol.13 (1), p.78-88
16.
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
by Ronco, Guglielmo, Dr
The lancet oncology, 2010, Vol.11 (3), p.249-257
17.
Present status of human papillomavirus vaccine development and implementation
by Herrero, Rolando, Dr
The lancet oncology, 2015, Vol.16 (5), p.e206-e216
18.
Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study
by Kocken, Mariëlle, MD
The lancet oncology, 2011, Vol.12 (5), p.441-450
19.
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neopl...
by Trimble, Cornelia L, Prof
The Lancet (British edition), 2015, Vol.386 (10008), p.2078-2088
20.
Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of...
by Carozzi, Francesca, PhD
The lancet oncology, 2013, Vol.14 (2), p.168-176
